Studies on soluble fibrin in plasma. I a. N-terminal analysis of a modified fraction I (Cohn) from plasma containing fibrinolytic inhibitors, and incubated with plasminogen-free human thrombin.
D000409:Alanine / Q000032:analysis; D000933:Antifibrinolytic Agents; D001224:Aspartic Acid / Q000032:analysis; D001777:Blood Coagulation; D001798:Blood Proteins / Q000032:analysis; D011232:Chemical Precipitation; D000431:Ethanol; D005337:Fibrin / Q000032:analysis*; D005340:Fibrinogen; D005973:Glutamine / Q000032:analysis; D005998:Glycine / Q000032:analysis; D006801:Humans; D066298:In Vitro Techniques; D010949:Plasma; D013917:Thrombin; D014443:Tyrosine / Q000032:analysis
D000933:Antifibrinolytic Agents; D001798:Blood Proteins; D005973:Glutamine; D001224:Aspartic Acid; D000431:Ethanol; D014443:Tyrosine; D005337:Fibrin; D005340:Fibrinogen; D013917:Thrombin; D000409:Alanine; D005998:Glycine